Trade in substandard and falsified medicines

Table of contents

Bibliographic information

Cover of book: Geopolitics of the Illicit
Open Access Full access

Geopolitics of the Illicit

Linking the Global South and Europe

Authors:
Series
Weltwirtschaft und internationale Zusammenarbeit
Volume
25
Publisher
Nomos, Baden-Baden
Copyright year
2022
ISBN-Print
978-3-7560-0015-9
ISBN-Online
978-3-7489-3594-0

Chapter information

Open Access Full access

Trade in substandard and falsified medicines

Authors:
ISBN-Print
978-3-7560-0015-9
ISBN-Online
978-3-7489-3594-0
Preview:

Bibliography

  1. Akuse, Rosamund Modupe/Eke, Felicia Uchezuba/Ademola, Adebowale Dele/Fajolu, Iretiola Bamikeolu/Gbelee, Henry Olusegun et al. (2012): "Diagnosing renal failure due to diethylene glycol in children in a resource-constrained setting". In: Pediatric Nephrology, 27, 6, pp. 1021-1028. Open Google Scholar doi.org/10.5771/9783748935940-191
  2. Alarcón-Jiménez, Oscar (2015): "The Medicrime Convention - Fighting against counterfeit medicine". In: Eurohealth International, 21, 4, pp. 24-27. Open Google Scholar doi.org/10.5771/9783748935940-191
  3. Almuzaini, Tariq/Choonara, Imti/Sammons, Helen (2013): "Substandard and counterfeit medicines. A systematic review of the literature". In: BMJ Open, 3, 8, e002923. Open Google Scholar doi.org/10.5771/9783748935940-191
  4. Attaran, Amir (2015): "Stopping murder by medicine. Introducing the Model Law on Medicine Crime". In: The American Journal of Tropical Medicine and Hygiene, 92, 6 Suppl, pp. 127-132. Open Google Scholar doi.org/10.5771/9783748935940-191
  5. Bassiony, Medhat M./Abdelghani, Mohamed/Salah El-Deen, Ghada M./Hassan, Mervat S./El-Gohari, Hayam/Youssef, Usama M. (2018): "Opioid use disorders attributed to tramadol among Egyptian university students". In: Journal of Addiction Medicine, 12, 2, pp. 150-155. Open Google Scholar doi.org/10.5771/9783748935940-191
  6. Basu, Debasish/Mahintamini, Tathagata/Ghosh, Abhishek/Roub, Fazle/Subodh, B. N./Mattoo, S. K./Avasthi, Ajit (2020): "Tapentadol, the new kid on the block in India. Is it time to worry?". In: Indian Journal of Psychiatry, 62, 6, pp. 697-702. Open Google Scholar doi.org/10.5771/9783748935940-191
  7. Bate, Roger/Jin, Ginger Zhe/Mathur, Aparna/Attaran, Amir (2014): "Poor quality drugs and global trade. A pilot study". National Bureau of Economic Research (NBER). At: <http://www.nber.org/papers/w20469> (accessed 23 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  8. BBC (2018): "Nigeria's Tramadol crisis. The drug fuelling death, despair and Boko Haram". At: <https://www.bbc.com/news/world-africa-44306086> (accessed 23 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  9. Bergen, Martin/Hoferichter, Reinhard (2017): "securPharm e. V. - der Schutzschild gegen gefälschte Arzneimittel". In: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 60, 11, pp. 1255-1260. Open Google Scholar doi.org/10.5771/9783748935940-191
  10. Buckley, Gillian J./Gostin, Lawrence O. (eds.) (2013): Countering the problem of falsified and substandard drugs. Washington, D.C.: The National Academies Press. At: <https://www.nap.edu/read/18272/chapter/1> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  11. Byaruhanga, Janet (2020): "How Africa can manufacture to meet its own pharmaceutical needs". Africa Renewal. At: <https://www.un.org/africarenewal/magazine/september-2020/how-africa-can-manufacture-meet-its-own-pharmaceutical-needs> (accessed 15 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  12. Companies House (2021): "Companies House". At: <https://www.gov.uk/government/organisations/companies-house> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  13. Dellasega, Maria/Vorrath, Judith (2020): "A gangster’s paradise? Transnational organised crime in the Covid-19 pandemic”. SWP Comment 2020/C 66. At: <https://www.swp-berlin.org/en/publication/a-gangsters-paradise-transnational-organised-crime-in-the-covid-19-pandemic> (accessed 26 January 2022). Open Google Scholar doi.org/10.5771/9783748935940-191
  14. Dugato, Marco/Riccardi, Michele/Polizzotti, Marcello (2014): "The theft of medicines from Italian hospitals". Transcrime - Joint Research Centre on Transnational Crime. At: <https://www.researchgate.net/publication/260487710_The_Theft_of_Medicines_from_Italian_Hospitals> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  15. EMCDDA, European Monitoring Centre for Drugs and Drug Addiction (2018): "Captagon: understanding today’s illicit market“. EMCDDA Papers. Publications Office of the European Union, Luxembourg. At: <https://www.emcdda.europa.eu/system/files/publications/9783/20184976_TDAU18002ENN_PDF.PDF> (accessed 20 September 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  16. EUIPO, European Union Intellectual Property Office (2020): "2020 Status report in IPF infringement". At: <https://www.opi.gr/images/various/2020_Status_Report_on_IPR_infringement_en.pdf> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  17. Europol (2020): "48 arrests and 6 organised crime groups dismantled in medicine-trafficking operation". At: <https://www.europol.europa.eu/newsroom/news/48-arrests-and-6-organised-crime-groups-dismantled-in-medicine-trafficking-operation> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  18. Europol (2021): "European Union serious and organised crime threat assessment (SOCTA). A corrupting influence: the infiltration and undermining of Europe’s economy and society by organised crime“. Publication Office of the European Union, Luxembourg. At: <https://www.europol.europa.eu/sites/default/files/documents/socta2021_1.pdf> (accessed 8 September 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  19. FDA, U.S. Food and Drug Administration (2021): "Generic Drugs". At: <https://www.fda.gov/drugs/buying-using-medicine-safely/generic-drugs> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  20. FIP, International Pharmaceutical Federation (2021): "Curriculum for pharmacy students on substandard and falsified medicines. Curriculum guide and competency framework". At: <https://www.fip.org/file/4917> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  21. Gnegel, Gesa/Hauk, Cathrin/Neci, Richard/Mutombo, Georges/Nyaah, Fidelis/Wistuba, Dorothee/Häfele-Abah, Christina/Heide, Lutz (2020): "Identification of falsified chloroquine tablets in Africa at the time of the COVID-19 pandemic". In: The American Journal of Tropical Medicine and Hygiene, 103, 1, pp. 73-76. Open Google Scholar doi.org/10.5771/9783748935940-191
  22. GPHF, Global Pharma Health Fund e.V. (2021): "The GPHF-Minilab™ - protection against counterfeit medicines". At: <https://www.gphf.org/en/minilab/> (accessed 19 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  23. Hagen, Nhomsai/Khuluza, Felix/Heide, Lutz (2020): "Quality, availability and storage conditions of oxytocin and misoprostol in Malawi". In: BMC Pregnancy and Childbirth, 20. No. 184. Open Google Scholar doi.org/10.5771/9783748935940-191
  24. Hall, Alexandra/Koenraadt, Rosa/Antonopoulos, Georgios A. (2017): "Illicit pharmaceutical networks in Europe. Organising the illicit medicine market in the United Kingdom and the Netherlands". In: Trends in Organized Crime, 20, 3, pp. 296-315. Open Google Scholar doi.org/10.5771/9783748935940-191
  25. Hall, Peter E./ Tagontong, Navaporn (2016): "Quality of medicines. Quality of misoprostol products". In: WHO Drug Information, 30, 1, pp. 35-39. Open Google Scholar doi.org/10.5771/9783748935940-191
  26. Hauk, Cathrin/Hagen, Nhomsai/Heide, Lutz (2021): "Identification of substandard and falsified medicines. Influence of different tolerance limits and use of authenticity inquiries". In: The American Journal of Tropical Medicine and Hygiene, 104, 5, pp. 1936-1945. Open Google Scholar doi.org/10.5771/9783748935940-191
  27. INCB, International Narcotics Control Board (2018): "Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances“. United Nations Office at Vienna. At: <https://www.incb.org/documents/PRECURSORS/TECHNICAL_REPORTS/2017/E_ebook_with_annexes.pdf> (accessed 27 April 2022). Open Google Scholar doi.org/10.5771/9783748935940-191
  28. INCB, International Narcotics Control Board (2019): "Report of the International Narcotics Control Board for 2019“. United Nations Office at Vienna. At: <https://www.incb.org/documents/Publications/AnnualReports/AR2019/Annual_Report_Chapters/English_ebook_AR2019.pdf> (accessed 27 April 2022). Open Google Scholar doi.org/10.5771/9783748935940-191
  29. INCB and WHO (2012): "Guide on estimating requirements for substances under international control“. United Nations Office. At: <https://www.incb.org/documents/Narcotic-Drugs/Guidelines/estimating_requirements/NAR_Guide_on_Estimating_EN_Ebook.pdf> accessed 27 April 2022). Open Google Scholar doi.org/10.5771/9783748935940-191
  30. INCO, UNODC and WHO (2021): "INCB, UNODC and WHO Joint Statement on Access to Controlled Medicines in Emergencies". At: <https://www.who.int/news/item/08-09-2021-incb-unodc-and-who-joint-statement-on-access-to-controlled-medicines-in-emergencies> (accessed 16 September 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  31. INTERPOL (2014): "Pharmaceutical crime and organized criminal groups. An analysis of the involvement of organized criminal groups in pharmaceutical crime since 2008". At: <https://www.republicoftogo.com/content/download/35515/742319/file/RAPPORT%20INTERPOL.pdf> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  32. INTERPOL (2020a): "Global operation sees a rise in fake medical products related to COVID-19". At: <https://www.interpol.int/News-and-Events/News/2020/Global-operation-sees-a-rise-in-fake-medical-products-related-to-COVID-19> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  33. INTERPOL (2020b): "INTERPOL warns of organized crime threat to COVID-19 vaccines". At: <https://www.interpol.int/News-and-Events/News/2020/INTERPOL-warns-of-organized-crime-threat-to-COVID-19-vaccines> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  34. INTERPOL (2020c): "Operation in the Middle East and North Africa targets pharmaceutical crime". At: <https://www.interpol.int/News-and-Events/News/2020/Operation-in-the-Middle-East-and-North-Africa-targets-pharmaceutical-crime> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  35. INTERPOL (2021a): "Fake COVID vaccine distribution network dismantled after INTERPOL alert". At: <https://www.interpol.int/News-and-Events/News/2021/Fake-COVID-vaccine-distribution-network-dismantled-after-INTERPOL-alert> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  36. INTERPOL (2021b): "Thousands of fake online pharmacies shut down in INTERPOL operation". At: <https://www.interpol.int/News-and-Events/News/2021/Thousands-of-fake-online-pharmacies-shut-down-in-INTERPOL-operation> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  37. IRACM, Institute de Recherche Anti-Contrefaçon de Médicaments/Przyswa, Eric (2013): "Counterfeit medicine and criminal organizations". At: <https://globalinitiative.net/wp-content/uploads/2017/12/IRACM-Counterfeit-Medicines-and-Criminal-Organizations-Oct-2013.pdf> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  38. Keteyian, Armen (2012): "How fake Avastin from overseas ends up in the U.S.". CBS News. At: <https://www.cbsnews.com/news/how-fake-avastin-from-overseas-ends-up-in-us/> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  39. Klein, Axel (2019): "Drug problem or medicrime? Distribution and use of falsified tramadol medication in Egypt and West Africa". In: Journal of Illicit Economies and Development, 1, 1, pp. 52-62. Open Google Scholar doi.org/10.5771/9783748935940-191
  40. McManus, Dominic/Naughton, Bernard David (2020): "A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies. A focus on context, prevalence, and quality". In: BMJ Global Health, 5, 8. Open Google Scholar doi.org/10.5771/9783748935940-191
  41. Mumphansha, Hazel/Nickerson, Jason W./Attaran, Amir/Overton, Sean/Curtis, Sharon/Mayer, Paul/Bould, M Dylan (2017): "An analysis of substandard Propofol detected in use in Zambian anesthesia". In: Anesthesia & Analgesia, 125, 2, pp. 616-619. Open Google Scholar doi.org/10.5771/9783748935940-191
  42. Newton, Paul N./Bond, Katherine C./Adeyeye, Moji/Antignac, Marie/Ashenef, Ayenew et al. (2020): "COVID-19 and risks to the supply and quality of tests, drugs, and vaccines". In: The Lancet Global Health, 8, 6, pp. e754-e755. Open Google Scholar doi.org/10.5771/9783748935940-191
  43. Newton, Paul N./Lee, Sue J./Goodman, Catherine/Fernández, Facundo M./Yeung, Shunmay et al. (2009): "Guidelines for field surveys of the quality of medicines. A proposal". In: PLOS Medicine, 6, 3, e1000052. Open Google Scholar doi.org/10.5771/9783748935940-191
  44. OECD, Organization for Economic Co-operation and Development/EUIPO (2020): "Trade in counterfeit pharmaceutical products". Paris: OECD Publishing. At: <https://www.oecd-ilibrary.org/content/publication/a7c7e054-en> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  45. Oyetunde, Olubukola O./Ogidan, Olayiwola/Akinyemi, Mary I./Ogunbameru, Adeteju A./Asaolu, Olubunmi F. (2019): "Mobile authentication service in Nigeria. An assessment of community pharmacists' acceptance and providers' views of successes and challenges of deployment". In: Pharmacy Practice, 17, 2, pp. 1449-1449. Open Google Scholar doi.org/10.5771/9783748935940-191
  46. Ozawa, Sachiko/Evans, Daniel R./Bessias, Sophia/Haynie, Deson G./Yemeke, Tatenda T./Laing, Sarah K. Laing/Herrington, James E. (2018): "Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries. A systematic review and meta-analysis". In: JAMA Network Open, 1, 4, e181662. Open Google Scholar doi.org/10.5771/9783748935940-191
  47. Peyraud, Nicolas/Rafael, Florentina/Parker, Lucy Anne/Quere, Michel/Alcoba, Gabriel et al. (2017): "An epidemic of dystonic reactions in central Africa". In: The Lancet Global Health, 5, 2, pp. e137-e138. Open Google Scholar doi.org/10.5771/9783748935940-191
  48. People’s Daily Online (2009): "China's ministries work together to bust online counterfeit drug dealers“. At: <http://en.people.cn/90001/90776/90882/6659053.html> (accessed 22 November 2021) Open Google Scholar doi.org/10.5771/9783748935940-191
  49. PQM, Promoting the Quality of Medicines (2018): "Promoting the Quality of Medicines Program annual performance report: Fiscal Year 2018, October 1, 2017-September 30, 2018“. U.S. Pharmacopeial Convention (USP). Rockville, MD: U.S. Agency for International Development by the Promoting the Quality of Medicines Program. At: <https://www.usp-pqm.org/sites/default/files/pqms/2018-annual-report-pqm.pdf> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  50. Progenerika (2020): "Where do our active ingredients come from?". At: <https://www.progenerika.de/studies/where-do-our-active-ingredients-come-from/?lang=en> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  51. Rahman, Mohammad S./Yoshida, Naoko/Tsuboi, Hirohito/Tomizu, Naoki/Endo, Jamie/Miyu, Onishi/Akimoto, Yoshio/Kimura, Kazuko (2018): "The health consequences of falsified medicines. A study of the published literature". In: Tropical Medicine & International Health, 23, 12, pp. 1294-1303. Open Google Scholar doi.org/10.5771/9783748935940-191
  52. Roche Pharma AG (2014): "Fälschungen des Arzneimittels Herceptin® 150 mg Pulver zur Herstellung eines Infusionslösungskonzentrats (Trastuzumab) - Verschiedene Chargen sind betroffen". Rote-Hand-Brief 22. April 2014. At: <https://www.akdae.de/Arzneimittelsicherheit/RHB/Archiv/2014/20140422.pdf> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  53. Schäfermann, Simon/Hauk, Cathrin/Wemakor, Emmanuel/Neci, Richard/Mutombo, Georges et al. (2020): "Substandard and falsified antibiotics and medicines against noncommunicable diseases in Western Cameroon and Northeastern Democratic Republic of Congo". In: The American Journal of Tropical Medicine and Hygiene, 103, 2, pp. 894-908. Open Google Scholar doi.org/10.5771/9783748935940-191
  54. Streit, Renz (2017): "Der Herceptin®-Fall". In: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 60, 11, pp. 1203-1207. Open Google Scholar doi.org/10.5771/9783748935940-191
  55. UNIFAB, Union des Fabricantes (2016): "Counterfeiting & Terrorism. Report 2016”. At: <https://euipo.europa.eu/ohimportal/documents/11370/71142/Counterfeiting+%26%20terrorism/7c4a4abf-05ee-4269-87eb-c828a5dbe3c6> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  56. UNODC, United Nations Office on Drugs and Crimes (2010): "Counterfeit Products". In: The Globalization of Crime. A Transnational Organized crime Threat Assessment, pp. 173-190. At: <https://www.unodc.org/documents/data-and-analysis/tocta/TOCTA_Report_2010_low_res.pdf> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  57. UNODC, United Nations Office on Drugs and Crimes (2011): "Resolution 20/6. Countering fraudulent medicines, in particular their trafficking". At: <https://www.unodc.org/documents/commissions/CCPCJ/Crime_Resolutions/2010-2019/2011/CCPCJ/Resolution_20-6.pdf> (accessed 23 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  58. UNODC, United Nations Office on Drugs and Crimes (2019): "Combating falsified medical product-related crime. A guide to good legislative practices". At: <https://www.unodc.org/documents/treaties/publications/19-00741_Guide_Falsified_Medical_Products_ebook.pdf> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  59. UNODC, United Nations Office on Drugs and Crimes (2021a): "At the crossroad of licit and illicit. Tramadol and other pharmaceutical opioids trafficking in West Africa". At: <https://www.unodc.org/documents/nigeria/Tramadol_Trafficking_in_West_Africa.pdf> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  60. UNODC, United Nations Office on Drugs and Crimes (2021b): "International Drug Control Conventions". At: <https://www.unodc.org/unodc/en/commissions/CND/conventions.html> (18 September 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  61. USP (2020): "<1850> Evaluation of Screening Technologies for Assessing Medicine Quality". In USP 43-NF 38. Rockville, MD: United States Pharmacopeial Convention. Open Google Scholar doi.org/10.5771/9783748935940-191
  62. Van Assche, Kerlijn/Caillet, Céline/Newton, Paul (2021a): "Medical Product Quality Report. COVID-19 Issues“. Issue 10, May 2021. Medicine Quality Research Group, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford. At: <https://www.iddo.org/document/medical-product-quality-report-covid-19-issues-issue-10-march-2021-main-text-plus-annexes> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  63. Van Assche, Kerlijn/Caillet, Céline/Newton, Paul (2021b): "Medical Product Quality Report. COVID-19 vaccines“. Issue 5, June 2021. Medicine Quality Research Group, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford. At: <https://www.iddo.org/sites/default/files/publication/2021-06/Medical%20Product%20Quality%20Report_COVID-19%20VACCINE%20issues_Up%20to%2031May2021.pdf> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  64. Vickers, Serena/Bernier, Matthew/Zambrzycki, Stephen/Fernández, Facundo M./Newton, Paul N./Caillet, Céline (2018): "Field detection devices for screening the quality of medicines. A systematic review". In: BMJ Global Health 3, 4, e000725. Open Google Scholar doi.org/10.5771/9783748935940-191
  65. Vorrath, Judith/Voss, Maike (2019): "The hidden dangers of falsified and substandard medicines.” SWP Comment 2019/C 25. At: <https://www.swp-berlin.org/publikation/the-hidden-dangers-of-falsified-and-substandard-medicines> (accessed 27 January 2022). Open Google Scholar doi.org/10.5771/9783748935940-191
  66. Wainer, Irving (1996): “Toxicology through a looking glass. Stereochemical questions and some answers”. In: Wong, Steven H. Y./Sunshine, Irving (eds.): Handbook of analytical therapeutic drug monitoring and toxicology. Boca Raton/New York: CRC Press, pp. 21-34. Open Google Scholar doi.org/10.5771/9783748935940-191
  67. WHO, World Health Organization (2013a): "Drug Alert No. 126. Contaminated Dextromethorpan active pharmaceutical ingredient". Information Exchange System. At: <https://www.who.int/medicines/publications/drugalerts/Final_Alert_126_Information_on_Dextromethorphan.pdf?ua=1> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  68. WHO, World Health Organization (2013b): "Drug Alert No. 129. Contaminated Dextromethorphan active pharmaceutical ingredient". Information Exchange System. At: <https://www.who.int/medicines/publications/drugalerts/App_Drug_Alert_No_129_Paraguay_Dextro.pdf?ua=1> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  69. WHO, World Health Organization (2016): "Annex 7: Guidelines on the conduct of surveys of the quality of medicines". WHO Expert Committee on Specifications for Pharmaceutical Preparations. Fifth report, pp. 227-261. WHO Technical Report Series No.996. At: <https://www.who.int/medicines/publications/pharmprep/WHO_TRS_996_web.pdf?ua> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  70. WHO, World Health Organization (2017a): "WHO Global Surveillance and Monitoring System for substandard and falsified medical products" At: <https://www.who.int/publications/i/item/9789241513425> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  71. WHO, World Health Organization (2017b): "Member State mechanism on substandard/spurious/falsely labelled/falsified/counterfeit medical products". At: <https://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_23-en.pdf> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  72. WHO, World Health Organization (2017c): "A study on the public health and socioeconomic impact of substandard and falsified medical products". At: <https://apps.who.int/iris/handle/10665/331690> (accessed July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  73. WHO, World Health Organization (2020a): "Urgent health challenges for the next decade”. At: <https://www.who.int/news-room/photo-story/photo-story-detail/urgent-health-challenges-for-the-next-decade> (accessed July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  74. WHO, World Health Organization (2020b): "WHO Medical Product Alert N°3/2020". At: <https://cdn.who.int/media/docs/default-source/essential-medicines/drug-alerts20/no3-2020-falsified-mp-forcovid-en.pdf?sfvrsn=cd866001_16> (accessed July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  75. WHO, World Health Organization (2020c): "WHO Medical Product Alert N°4/2020". At: <https://www.who.int/news/item/09-04-2020-medical-product-alert-n4-2020> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  76. WHO, World Health Organization (2021a): "Evaluating and publicly designating regulatory authorities as WHO listed authorities: policy document". At: <https://www.who.int/publications/i/item/9789240023444> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  77. WHO, World Health Organization (2021b): "Policy paper on traceability of medical products". At: <https://www.who.int/publications/i/item/policy-paper-on-traceability-of-medical-products> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  78. WHO, World Health Organization (2021c): "WHO - Prequalification of medical products (IVDs, medicines, vaccines and immunization devices, vector control)". At: <https://extranet.who.int/pqweb/medicines> (accessed 20 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  79. WHO, World Health Organization (2021d): "WHO global surveillance and monitoring system". At: <https://www.who.int/who-global-surveillance-and-monitoring-system> (accessed 22 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  80. WHO, World Health Organization (2021e): "WHO quality assurance policy for the procurement of essential medicines and other health products". At: <https://www.who.int/publications/i/item/9789240023789> (accessed 23 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191
  81. Yadav, Prashant/Teta, Helen Lega/Babaley, Magalie (2011): "The world medicines situation 2011. Storage and supply chain management" Geneva: World Health Organization. At: <https://www.asrames.org/wp-content/uploads/2016/07/THE-WORLD-MEDICINES-SITUATION-2011-STORAGE-AND-SUPPLY-CHAIN-MANAGEMENT.pdf> (accessed 26 July 2021). Open Google Scholar doi.org/10.5771/9783748935940-191

Citation

Download RIS Download BibTex

Downloads

Download chapter (PDF) Download complete (PDF)

Notice

This work is protected by copyright and may only be used in accordance with the provisions of the Terms of Use and License Agreement. Any use of the work beyond this is expressly prohibited and will be prosecuted.

Share via email

Media